In 2021, the platform achieved an Authorization to Operate with Conditions (ATO-C) from the Department of the Air Force for conducting IL4 meetings.
Figure 1: Upregulated cellular responses to human IL4 after transfection with the Ile50 variant of IL4Rα compared with the Val50 variant a, Cell proliferation by MTT dye assay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback